A case of sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis complicated by concurrent subacute thyroiditis
Sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus are gaining popularity due to their cardioprotective and renoprotective effects, yet SGLT2 inhibitors are increasingly associated with euglycemic diabetic ketoacidosis, which could be life-threatening if...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Journal of Clinical and Translational Endocrinology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214624522000181 |